Vikram S. Brar
Impact in
- Ophthalmology top 1%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
- Retinal and Optic Conditions
- Ocular Diseases and Behçet’s Syndrome
-
- Retinal and Macular Surgery
- Retinal Imaging and Analysis
Papers in
-
- Retinal Diseases and Treatments 5
- Retinal and Optic Conditions 1
-
- Retinal and Macular Surgery 4
- Corneal Surgery and Treatments 1
- Co-authors
- Ravi Murthy (15 shared papers)Kakarla V Chalam (10 shared papers)Sandeep Grover (7 shared papers)K V Chalam (8 shared papers)Swati Agarwal (2 shared papers)Shailesh Gupta (3 shared papers)Sankarathi Balaiya (2 shared papers)Rajesh Sharma (1 shared paper)
- Journals
- European Journal of Ophthalmology (4 papers)Retina (2 papers)Cornea (1 paper)Journal of Ocular Pharmacology and Therapeutics (1 paper)American Journal of Ophthalmology (1 paper)
- Partner nations
- United StatesRussiaGermany
In The Last Decade
Vikram S. Brar
20 papers receiving 604 citations
Peers
Comparison fields: 5 of 46
- Ophthalmology 348
- Radiology, Nuclear Medicine and Imaging 209
- Neurology 25
- Molecular Biology 57
- Biomedical Engineering 34
Countries citing papers authored by Vikram S. Brar
This map shows the geographic impact of Vikram S. Brar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikram S. Brar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikram S. Brar more than expected).
Fields of papers citing papers by Vikram S. Brar
This network shows the impact of papers produced by Vikram S. Brar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikram S. Brar. The network helps show where Vikram S. Brar may publish in the future.
Co-authors
The 12 scholars most cited alongside Vikram S. Brar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 232 | |
| 2 | 2010 | 113 | |
| 3 | Bevacizumab neutralizes the protective effect of vascular endothelial growth factor on retinal ganglion cells. | 2010 | 54 |
| 4 | 2008 | 45 | |
| 5 | 2011 | 34 | |
| 6 | 2009 | 33 | |
| 7 | 2010 | 25 | |
| 8 | 2010 | 23 | |
| 9 | 2009 | 22 | |
| 10 | 2011 | 10 | |
| 11 | 2010 | 9 | |
| 12 | 2009 | 8 | |
| 13 | 2012 | 5 | |
| 14 | 2008 | 4 | |
| 15 | 2008 | 3 | |
| 16 | 2010 | 3 | |
| 17 | 2009 | 3 | |
| 18 | 2010 | 2 | |
| 19 | 2009 | 2 | |
| 20 | Vascular Endothelial Growth Factor Protects Against Oxidative Stress in Differentiated Retinal Ganglion Cells | 2009 | 1 |
About Vikram S. Brar
Vikram S. Brar is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging, Surgery, Pathology and Forensic Medicine and Neurology, having authored 20 papers that have together received 631 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (5 papers), Retinal and Macular Surgery (4 papers), Ophthalmology and Visual Impairment Studies (1 paper), Nitric Oxide and Endothelin Effects (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper), Retinal and Optic Conditions (1 paper), Corneal Surgery and Treatments (1 paper) and Ocular Surface and Contact Lens (1 paper). The work is most often cited by research in Ophthalmology (348 citations), Radiology, Nuclear Medicine and Imaging (209 citations), Neurology (25 citations), Molecular Biology (57 citations) and Biomedical Engineering (34 citations). Vikram S. Brar has collaborated with scholars based in United States, Russia and Germany. Frequent co-authors include Ravi Murthy, Kakarla V Chalam, Sandeep Grover, K V Chalam, Swati Agarwal, Shailesh Gupta, Sankarathi Balaiya, Rajesh Sharma, KV Chalam and Shailesh Kumar Gupta. Their work appears in journals such as European Journal of Ophthalmology, Retina, Cornea, Journal of Ocular Pharmacology and Therapeutics and American Journal of Ophthalmology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.